⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12843359 | 0.83 | — | — | |
| SCHEMBL10309809 | 0.83 | — | — | |
| SCHEMBL17524675 | 0.83 | — | — | |
| SCHEMBL16360193 | 0.80 | — | — | |
| SCHEMBL23030320 | 0.79 | KDM4E (0.38) | — | |
| SCHEMBL19155459 | 0.79 | KDM4E (0.42) | — | |
| SCHEMBL13261389 | 0.79 | KDM4E (0.42) | — | |
| SCHEMBL17538803 | 0.79 | KDM4E (0.50) | — | |
| SCHEMBL18231569 | 0.78 | KDM4E (0.41) | — | |
| SCHEMBL17377986 | 0.78 | KDM4E (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9896715-B2 | Method for analyzing formyl glycine residue | JCR PHARMACEUTICALS CO., LTD. (JP) | 2018-02-20 | — | — | US | disclosed |
| WO-2016178979-A1 | COMPOSITIONS FOR COLON CLEANSING AND THE TREATMENT OF GASTROINTESTINAL DISORDERS | IRONWOOD PHARMACEUTICALS, INC. (US) | 2016-11-10 | — | — | WO | disclosed |
| US-20160303247-A1 | Antibody-Drug Conjugates and Related Compounds, Compositions, and Methods | IGENICA BIOTHERAPEUTICS, INC. (US) | 2016-10-20 | — | — | US | disclosed |
| US-20150044715-A1 | METHOD FOR ANALYZING FORMYL GLYCINE RESIDUE | JCR PHARMACEUTICALS CO., LTD. (JP) | 2015-02-12 | — | — | US | disclosed |
| EP-1850832-B1 | ADJUVANTING MATERIAL | LIPOTEK PTY LTD (AU) | 2014-12-31 | — | — | EP | disclosed |
| US-20140363454-A1 | Antibody-Drug Conjugates, Compositions and Methods of Use | IGENICA BIOTHERAPEUTICS, INC. (US) | 2014-12-11 | — | — | US | disclosed |
| WO-2014197871-A2 | ANTIBODY-DRUG CONJUGATES, COMPOSITIONS AND METHODS OF USE | IGENICA BIOTHERAPEUTICS, INC. (US) | 2014-12-11 | — | — | WO | disclosed |
| EP-1984386-B1 | Methods for the synthesis of two or more dicarba bridges in organic compounds | SYNGENE LTD (AU) | 2013-10-09 | — | — | EP | disclosed |
| US-20130224228-A1 | Antibody-Drug Conjugates and Related Compounds, Compositions, and Methods | IGENICA, INC. (US) | 2013-08-29 | — | — | US | disclosed |
| WO-2013085925-A1 | ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, COMPOSITIONS, AND METHODS | IGENICA, INC. (US) | 2013-06-13 | — | — | WO | disclosed |
| WO-2007093013-A1 | METHODS FOR THE SYNTHESIS OF DICARBA BRIDGES IN ORGANIC COMPOUNDS | MONASH UNIVERSITY (AU) | 2007-08-23 | — | — | WO | disclosed |